These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 20661740)

  • 1. Serologic response to Epstein-Barr virus antigens in patients with systemic lupus erythematosus: a controlled study.
    Esen BA; Yılmaz G; Uzun S; Ozdamar M; Aksözek A; Kamalı S; Türkoğlu S; Gül A; Ocal L; Aral O; Inanç M
    Rheumatol Int; 2012 Jan; 32(1):79-83. PubMed ID: 20661740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Investigation of Epstein-Barr virus and herpes simplex virus markers by serological and molecular methods in patients with rheumatoid arthritis and systemic lupus erythematosus].
    Us T; Cetin E; Kaşifoğlu N; Kaşifoğlu T; Akgün Y
    Mikrobiyol Bul; 2011 Oct; 45(4):677-83. PubMed ID: 22090298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of clinical and serological parameters of systemic lupus erythematosus patients with Epstein-Barr virus antibody profile.
    Chougule D; Nadkar M; Rajadhyaksha A; Pandit-Shende P; Surve P; Dawkar N; Khadilkar P; Patwardhan M; Kaveri S; Ghosh K; Pradhan V
    J Med Virol; 2018 Mar; 90(3):559-563. PubMed ID: 28734074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to early EBV, CMV, and HHV6 antigens in systemic lupus erythematosus patients.
    Rasmussen NS; Draborg AH; Nielsen CT; Jacobsen S; Houen G
    Scand J Rheumatol; 2015; 44(2):143-9. PubMed ID: 25562120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Systemic lupus erythematosus and Epstein-Barr virus].
    Tazi I; Fehri S; Elghrari K; Ouazzani T; Benchemsi N
    East Mediterr Health J; 2009; 15(3):701-8. PubMed ID: 19731786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus antibodies mark systemic lupus erythematosus and scleroderma patients negative for anti-DNA.
    Fattal I; Shental N; Molad Y; Gabrielli A; Pokroy-Shapira E; Oren S; Livneh A; Langevitz P; Pauzner R; Sarig O; Gafter U; Domany E; Cohen IR
    Immunology; 2014 Feb; 141(2):276-85. PubMed ID: 24164500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus early antigen diffuse (EBV-EA/D)-directed immunoglobulin A antibodies in systemic lupus erythematosus patients.
    Draborg AH; Jørgensen JM; Müller H; Nielsen CT; Jacobsen S; Iversen LV; Theander E; Nielsen LP; Houen G; Duus K
    Scand J Rheumatol; 2012 Aug; 41(4):280-9. PubMed ID: 22646970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High prevalence of immunoglobulin A antibody against Epstein-Barr virus capsid antigen in adult patients with lupus with disease flare: case control studies.
    Chen CJ; Lin KH; Lin SC; Tsai WC; Yen JH; Chang SJ; Lu SN; Liu HW
    J Rheumatol; 2005 Jan; 32(1):44-7. PubMed ID: 15630723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between cytomegalovirus infection and Raynaud's phenomenon in lupus nephritis.
    Stratta P; Canavese C; Ciccone G; Santi S; Quaglia M; Ghisetti V; Marchiaro G; Barbui A; Fop F; Cavallo R; Piccoli G
    Nephron; 1999 Jun; 82(2):145-54. PubMed ID: 10364707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study.
    Ascherio A; Munger KL; Lennette ET; Spiegelman D; Hernán MA; Olek MJ; Hankinson SE; Hunter DJ
    JAMA; 2001 Dec; 286(24):3083-8. PubMed ID: 11754673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exposure to Epstein-Barr virus infection is associated with mild systemic lupus erythematosus disease.
    Zandman-Goddard G; Berkun Y; Barzilai O; Boaz M; Blank M; Ram M; Sherer Y; Anaya JM; Shoenfeld Y
    Ann N Y Acad Sci; 2009 Sep; 1173():658-63. PubMed ID: 19758212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Epstein-Barr virus infection with systemic lupus erythematosus in Taiwan.
    Lu JJ; Chen DY; Hsieh CW; Lan JL; Lin FJ; Lin SH
    Lupus; 2007; 16(3):168-75. PubMed ID: 17432101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-Time PCR of cytomegalovirus and Epstein-Barr virus in adult Egyptian patients with systemic lupus erythematosus.
    Mohamed AE; Hasen AM; Mohammed GF; Elmaraghy NN
    Int J Rheum Dis; 2015 May; 18(4):452-8. PubMed ID: 24341363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated immunoglobulin G antibodies to the proline-rich amino-terminal region of Epstein-Barr virus nuclear antigen-2 in sera from patients with systemic connective tissue diseases and from a subgroup of Sjögren's syndrome patients with pulmonary involvements.
    Yamazaki M; Kitamura R; Kusano S; Eda H; Sato S; Okawa-Takatsuji M; Aotsuka S; Yanagi K
    Clin Exp Immunol; 2005 Mar; 139(3):558-68. PubMed ID: 15730403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of evidence of active lytic replication of Epstein-Barr and cytomegaloviruses in patients with systemic lupus erythematosus.
    Lau CS; Yuen KY; Chan KH; Wong RW
    Chin Med J (Engl); 1998 Jul; 111(7):660-5. PubMed ID: 11245059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of antibodies to the Epstein-Barr virus nuclear antigens in the sera from patients with systemic lupus erythematosus.
    Kitagawa H; Iho S; Yokochi T; Hoshino T
    Immunol Lett; 1988 Mar; 17(3):249-52. PubMed ID: 2836302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential role of the Epstein-Barr virus in systemic lupus erythematosus autoimmunity.
    Incaprera M; Rindi L; Bazzichi A; Garzelli C
    Clin Exp Rheumatol; 1998; 16(3):289-94. PubMed ID: 9631751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus and disease activity in multiple sclerosis.
    Buljevac D; van Doornum GJ; Flach HZ; Groen J; Osterhaus AD; Hop W; van Doorn PA; van der Meché FG; Hintzen RQ
    J Neurol Neurosurg Psychiatry; 2005 Oct; 76(10):1377-81. PubMed ID: 16170080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of primary versus reactivated Epstein-Barr virus infection in patients with VCA IgG-, VCA IgM- and EBNA-1-antibodies and suspected infectious mononucleosis.
    Nystad TW; Myrmel H
    J Clin Virol; 2007 Apr; 38(4):292-7. PubMed ID: 17336144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated antinuclear antibodies and altered anti-Epstein-Barr virus immune responses.
    Cuomo L; Cirone M; Di Gregorio AO; Vitillo M; Cattivelli M; Magliocca V; Maiorano S; Meledandri M; Scagnolari C; La Rocca S; Trivedi P
    Virus Res; 2015 Jan; 195():95-9. PubMed ID: 25300805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.